Federal contract award
75N95024C00021
ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $1.9M |
| Current contract value | $1.9M |
| Potential contract value / ceiling | $7.0M |
| Start date | Aug 4, 2024 |
| Current end date | Aug 3, 2027 |
| Potential end date | Aug 3, 2029 |
| Latest award activity | Aug 4, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 7 of 7 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 4, 2026 | P00006 | $0 | EO14398. ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. PERIOD OF PERFORMANCE: AUGUST 4, 2024 - AUGUST 3, 2027. |
| May 8, 2026 | P00005 | $561.1K | ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. PERIOD OF PERFORMANCE: AUGUST 4, 2024 - AUGUST 3, 2027. |
| Mar 13, 2026 | P00004 | $0 | ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. PERIOD OF PERFORMANCE: AUGUST 4, 2024 - AUGUST 3, 2026. |
| Feb 20, 2026 | P00003 | $0 | ACST OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. PERIOD OF PERFORMANCE: AUGUST 4, 2024 - AUGUST 3, 2026. |
| Jul 21, 2025 | P00002 | $543.7K | EOI::IMPLEMENTING THE PRESIDENT'S DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI ACST OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. PERIOD OF PERFORMANCE: AUGUST 4, 2024 - AUGUST 3, 2026. |
| Sep 18, 2024 | P00001 | $747.6K | ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. |
| Aug 1, 2024 | 0 | $0 | ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. |
Estimated positioning window
Aug 3, 2028 – Feb 3, 2029
60/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 60/100. Available recorded signals: 55 points.
- Contract end 2029-08-03 (1006 days from calculation)
- +15 points
- 173 historical awards in this buyer and category group
- +15 points
- 7 recorded award transactions
- +10 points
- Latest award action: 2026-08-04
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Robert Bailey | Contact | rob.bailey@nih.gov 3014517586 | Source | Apr 11, 2024 |
| Josh Lazarus | Contact | josh.lazarus@nih.gov 3014436677 | Source | Apr 11, 2024 |
| Robert Bailey | Contact | rob.bailey@nih.gov 3014517586 | Source | Apr 11, 2024 |
| Josh Lazarus | Contact | josh.lazarus@nih.gov 3014436677 | Source | Apr 11, 2024 |
| Robert Bailey | Contact | rob.bailey@nih.gov 3014517586 | Source | Mar 20, 2024 |
| Josh Lazarus | Contact | josh.lazarus@nih.gov 3014436677 | Source | Mar 20, 2024 |
| Robert Bailey | Contact | rob.bailey@nih.gov 3014517586 | Source | Feb 26, 2024 |
| Josh Lazarus | Contact | josh.lazarus@nih.gov 3014436677 | Source | Feb 26, 2024 |
| Robert Bailey | Contact | rob.bailey@nih.gov 3014517586 | Source | Feb 26, 2024 |
| Josh Lazarus | Contact | josh.lazarus@nih.gov 3014436677 | Source | Feb 26, 2024 |
| Robert Bailey | Contact | rob.bailey@nih.gov 3014517586 | Source | Jan 24, 2024 |
| Josh Lazarus | Contact | josh.lazarus@nih.gov 3014436677 | Source | Jan 24, 2024 |
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.